PF-Atlas › Clinical Trials › NCT03364218

Nebulized N-Acetyl Cysteine for Bronchiolitis in Inpatient Hospital Use

N-Acetyl Cysteine · Phase 4

Registry ID
NCT03364218
Phase
Phase 4
Status
Unknown
Drug / intervention
N-Acetyl Cysteine
Sponsor
Carilion Clinic
Start
2018-02-01

About this trial

N-Acetyl Cysteine is evaluated in NCT03364218, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Carilion Clinic. Current status: Unknown.

View NCT03364218 on ClinicalTrials.gov →

Explore related

All N-Acetyl Cysteine trialsAll IPF trials

Related trials

N-acetyl cysteine — NCT04300920N-Acetyl Cysteine — NCT03063021
Medical disclaimer. This page summarizes public trial data for NCT03364218 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.